Guides / Sermorelin dosage: what online providers prescribe
Sermorelin dosage: what online providers prescribe
The doses and schedules that online sermorelin providers publish, side by side, next to the doses used in the approved pediatric use and in published studies in adults.
Last revised November 12, 2026. This page is not medical advice.
Doses published by each provider
This is what each provider states on its own pages. Several publish no dose at all and leave it to the prescriber.
| Provider | Dose and schedule published | From, per month |
|---|---|---|
| bmiMD | Injection: one 5 mL vial at 2 mg/mL (10 mg) per month, about 30 injections. No dose is published for the tablets on the page we read. | $69 |
| Strut Health | Lozenge: once daily, 30 per month. Injection: 5 days on, 2 days off. | $99 |
| Brightmeds | Not stated on the pages we read | $129 |
| Enhanced | 250 mcg up to 400 mcg daily, as a nightly subcutaneous injection. | $129 |
| RNK Health | Not stated on the pages we read | $129 |
| AgelessRx | Not published. The page also lists a monthly plan without its price, and a nasal spray "starting at $149 / mo" without saying whether that is the regular price. | $149 |
| ShyftMD | Not stated on the pages we read | $149 |
| Taurus | The page gives the strength as "2mcg/mL (5mL per bottle)" and no dosing schedule. | $179 |
| ReadyRx | Dissolving tablets: 1000 mcg. The injection and the dissolving tablet are listed at the same prices. | $185 |
| Maximus | 1 mg, 5 days a week (0.75 mg in California for some peptides). One vial is 20 mg, a 28-day supply at standard dosing. | $199.99 |
| Direct Meds | 300 mcg nightly, Monday to Friday, at the start, then 600 mcg nightly, Monday to Friday. | $249 |
Doses in the approved use and in studies
Sermorelin was approved for children with growth failure caused by idiopathic growth hormone deficiency.2 A review of that use describes a dose of 30 micrograms per kilogram of body weight, injected under the skin once daily at bedtime.1
The published studies in adults each used a different regimen:
| Study | Participants | Regimen | Duration |
|---|---|---|---|
| Corpas, 19923 | 10 healthy men, average age 68 | 0.5 mg or 1 mg under the skin, twice daily | 14 days at each dose |
| Vittone, 19974 | 11 healthy men aged 64 to 76 | 2 mg under the skin, nightly | 6 weeks |
| Khorram, 19975 | 19 adults aged 55 to 71 | 10 micrograms per kilogram under the skin, nightly (a modified analog) | 16 weeks |
The authors of the six-week study concluded that single nightly doses were less effective than multiple daily doses at producing growth hormone and IGF-I effects.4
These were research protocols in small groups. They are not dosing recommendations.
Why the dose changes the price
Two plans at the same monthly price can ship different amounts of medication. The fair comparison is the price per milligram, which we show on the comparison table whenever a provider publishes how much it ships per month. Most do not.
Who decides the dose
The prescriber does. This page does not tell you what dose to take. Because compounded drugs are not FDA-approved, the agency does not verify their quality before they are marketed, so ask the prescriber which pharmacy prepares the medication and at what strength.6
Sources
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57. Read November 12, 2026.
- FDA, Federal Register, March 4, 2013: Determination that Geref (sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness. Read November 12, 2026.
- Corpas E, et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5. Read November 12, 2026.
- Vittone J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96. Read November 12, 2026.
- Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997;82(5):1472-9. Read November 12, 2026.
- FDA, Compounding and the FDA: Questions and Answers. Read November 12, 2026.
Nothing on this page is medical advice. See the medical disclaimer.